rdf:type |
|
lifeskim:mentions |
umls-concept:C0021149,
umls-concept:C0035648,
umls-concept:C0205127,
umls-concept:C0220825,
umls-concept:C0311400,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0449445,
umls-concept:C0680063,
umls-concept:C0948265,
umls-concept:C2603343
|
pubmed:issue |
9
|
pubmed:dateCreated |
2007-8-28
|
pubmed:abstractText |
The metabolic syndrome (MetS) is associated with increased cardiovascular risk. We evaluated the relative contributions of circulating biomarkers representing distinct biological pathways to the incidence of MetS and to longitudinal changes of its constituent risk factors.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1524-4539
|
pubmed:author |
pubmed-author:BenjaminEmelia JEJ,
pubmed-author:D'AgostinoRalph BRBSr,
pubmed-author:FoxCaroline SCS,
pubmed-author:IngelssonErikE,
pubmed-author:JacquesPaul FPF,
pubmed-author:LanierKatherine JKJ,
pubmed-author:LarsonMartin GMG,
pubmed-author:LevyDanielD,
pubmed-author:PencinaMichael JMJ,
pubmed-author:SelhubJacobJ,
pubmed-author:SpangenbergEE,
pubmed-author:ToflerGeoffrey HGH,
pubmed-author:VasanRamachandran SRS,
pubmed-author:WangThomas JTJ
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
984-92
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17698726-Aldosterone,
pubmed-meshheading:17698726-Biological Markers,
pubmed-meshheading:17698726-Blood Circulation,
pubmed-meshheading:17698726-Blood Glucose,
pubmed-meshheading:17698726-C-Reactive Protein,
pubmed-meshheading:17698726-Cardiovascular Diseases,
pubmed-meshheading:17698726-Child,
pubmed-meshheading:17698726-Follow-Up Studies,
pubmed-meshheading:17698726-Humans,
pubmed-meshheading:17698726-Incidence,
pubmed-meshheading:17698726-Insulin,
pubmed-meshheading:17698726-Longitudinal Studies,
pubmed-meshheading:17698726-Metabolic Syndrome X,
pubmed-meshheading:17698726-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:17698726-Risk Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
|
pubmed:affiliation |
Framingham Heart Study, Boston University School of Medicine, Framingham, MA 01702-5803, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|